Dotmp SM-153 clinical trials
Also written 153Sm-DOTMP.
How each study uses dotmp SM-153 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the dotmp SM-153 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2022 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Telix Pharmaceuticals (Innovations) Pty Limited (1) · QSAM Therapeutics, Inc. (1) · Albert Einstein College of Medicine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test dotmp SM-153.
- Apr 2027Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone PainPhase 1 · Telix Pharmaceuticals (Innovations) Pty Limited
Studies
Open first, then newest update. How each study uses dotmp SM-153 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone PainRecruitingPhase 1Telix Pharmaceuticals (Innovations) Pty LimitedNCT07197645Written as 153Sm-DOTMP
- A Dose Finding Study to Treat Bone Tumor(s)TerminatedPhase 1QSAM Therapeutics, Inc.NCT06008483Written as 153-Sm-DOTMP (Samarium-153-DOTMP)
- A Dose Finding Study of CycloSam® Combined With External Beam RadiotherapyWithdrawnPhase 1Albert Einstein College of MedicineNCT03612466Written as 153Sm-DOTMP
Codes
What other systems call dotmp SM-153 · ClinicalTrials.gg INT017858
- UNII (FDA) S5NN2E9ZKFDOTMP SM-153One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | S5NN2E9ZKF | DOTMP SM-153 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.